Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of KL280006 injection for postoperative analgesia after abdominal laparoscopic surgery
ChiCTR2200058227Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of KL280006 in acute postoperative pain (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Summed pain intensity differences within 24 hours. Started Apr 2022; status: recruiting.
02
Drugs
KL280006
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2200058227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058227.